ReviewCurrent opinion in pharmacology2018

Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease.

Gunasingh J Masilamoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.